News

IXO Therapeutics is a start-up from the Natural Environment Research Council (NERC) and will focus on developing intellectual property (IP) derived from both NERC and the University of

The circumsporozoite protein (CSP) has been identified as a potential target in the development of vaccines focused on the earlier stages of malaria infection. The researchers are working

Novartis Pharma and Aventis, who have been involved in legal dispute over rights of anti-rabies vaccine Rabipur, have agreed to settle their dispute following the transaction. Until February

Zerhouni will report directly to Christopher Viehbacher, CEO of Sanofi-aventis, and join the executive committee and the management committee. Sanofi-aventis said that since Zerhouni appointment as scientific advisor

China Pharma’s company’s gross profit increased by 18% to $4.69m as compared to $3.97m for the same quarter in 2009. Operating income decreased by 79% to $689,213 from

Meda and GSK are also pursuing further discussions on additional OTC acquisitions in the US market. Meda is an international specialty pharma company engaged in marketing and product

PJP transforms proteins, peptides and delicate small molecules into drugs. It also designs optimised pharmaceutical formulations and delivery systems that are stable, convenient and safe. The company develops

Under the agreement, TRL and Anaphore will generate novel trivalent proteins called Atrimers that can be programmed to bind to and activate or inhibit targets of interest. The

Immunomedics and UCB said that each study will will randomise 780 subjects in the study, with approximately 130 planned investigational sites per study. The primary objective of the